GleamWall
中文EN

RMTG Regenerative Medical Technology Group Inc.

Retail-Retail Stores, NEC · OTC · SEC CIK 1760026 · Fiscal year ends 12/31

Financial factors as of 2026-06-30 (2026Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY94.3%
TTM net income YoY-155.5%
TTM EPS YoY-55.6%
Revenue 3-yr CAGR66.0%
Net income 3-yr CAGR—

Margins

Gross margin59.8%
Operating margin0.5%
Net margin-101.2%
FCF margin-6.2%
EBITDA margin4.3%

Returns

ROE—
ROA-184.4%
ROIC (approx.)—
Asset turnover1.82x

Leverage & solvency

Liabilities / assets771.0%
Debt / equity—
Current ratio0.05x
Interest coverage0.00x

Cash quality & payout

Operating cash flow / net income-0.03x
Accruals ratio-189.6%
Payout ratio—
Capex / revenue9.0%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$5.10M$4.11M
Cost of revenue$2.29M$1.28M
Gross profit$2.81M$2.82M
SG&A expense$1.12M$798,316
Operating income-$867,162$81,181
Interest expense$7.45M$5.64M
Income tax-$1.64M-$1.16M
Net income-$7.81M-$5.56M
EBITDA-$586,095$301,740
EPS (basic)-0.62-0.44
EPS (diluted)-0.62-0.44
Weighted avg. shares (diluted)12.63M12.53M
Balance sheet
Cash & equivalents$956,718$1.17M
Receivables$43,815$22,605
Inventory$159,277$10,115
Current assets$1.22M$1.25M
PP&E, net$870,759$451,703
Goodwill$1.68M$1.68M
Intangibles$61,464$159,004
Total assets$4.49M$3.82M
Current liabilities$38.13M$28.97M
Total liabilities$40.54M$31.18M
Shareholders' equity-$36.05M-$27.36M
Shares outstanding13.14M12.54M
Cash flow statement
Operating cash flow-$706,519$850,699
Capital expenditure$602,583$215,419
Free cash flow-$1.31M$635,280
Investing cash flow-$602,583-$215,419
Financing cash flow$1.10M—
Depreciation & amortization$281,067$220,559

Free plan shows the latest 2 periods; Pro shows all 9 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.